Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,198,910,733
-$2,558,596,473 QoQ
Shares Held
15,437,458
-1.0% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 47.143551742780446.ToString("F0")%
Shared 0.ToString("F0")%
None 52.85644825721955.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. LLY ranks #1 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,198,910,733 | 15,437,458 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,757,507,206 | 15,593,019 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $11,586,805,839 | 15,185,853 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $11,590,438,673 | 14,868,496 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $12,284,887,613 | 14,874,366 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,100,662,112 | 14,379,096 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $12,895,868,434 | 14,556,142 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $12,423,627,065 | 13,722,003 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $10,167,597,220 | 13,069,563 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $7,380,185,142 | 12,660,717 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,738,603,077 | 12,545,572 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,844,267,889 | 12,461,657 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,170,306,680 | 12,143,459 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,411,739,180 | 12,059,204 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,705,717,776 | 8,367,768 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,432,744,048 | 7,503,143 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,137,862,265 | 3,973,399 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,055,950,382 | 3,822,860 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $872,913,594 | 3,778,029 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $877,413,410 | 3,822,819 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $660,096,518 | 3,533,329 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $570,335,436 | 3,377,964 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $445,975,080 | 3,012,938 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $451,070,096 | 2,747,412 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $398,133,470 | 2,870,051 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||